OpinionAugust 25, 2021
Alzheimer’s, Inc.: When a Hypothesis Becomes Too Big to Fail
This summer’s controversy surrounding the FDA’s shocking approval of the drug aducanumab provides a window into a scientific field in crisis
Stories by Peter J. Whitehouse
Peter J. Whitehouse, M.D., Ph.D., is co-author of American Dementia: Brain Health in an Unhealthy Society (Johns Hopkins University Press). www.americandementia.com.